Back to JHPCYView Full LandscapeView full pipeline
Phase 2
Development Phase
1
Upcoming Catalysts
0
Historical Events
0
Regulatory Approvals
Upcoming Catalysts
What are catalysts?Competitive Landscape
10 competitors in Diabetes Mellitus, Type 2
NVOInsulin Glargine 100U/mL
Phase 3LLYHuman Insulin Inhalation Powder
Phase 3LLYInsulin lispro mix 25
Phase 3LLYDetemir
Phase 3NVOInsulin Icodec
Phase 3Drug Information
Patent & Exclusivity
No patent data available. Pre-approval drugs may not have Orange Book listings.
Drug Science
Mechanism of action & safety profile
Related Pipeline
apatinibPhase 3
Non-Small-Cell Lung Cancer
SHR6390Phase 3
Hormone Receptor Positive,Human Epidermal Receptor 2 Negative, Node-positive, High Risk, Early Stage，Female Breast Cancer
PyrotinibPhase 3
HER2-positive Breast Cancer
SHR-1209Phase 3
Primary Hypercholesterolemia
SHR-1210Phase 3
Nasopharyngeal Carcinoma
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts